BARBOLINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.137
EU - Europa 2.367
AS - Asia 2.326
SA - Sud America 345
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 52
OC - Oceania 13
Totale 9.308
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.019
IT - Italia 772
SG - Singapore 700
CN - Cina 539
GB - Regno Unito 363
IE - Irlanda 316
VN - Vietnam 247
BR - Brasile 237
HK - Hong Kong 234
DE - Germania 185
BD - Bangladesh 175
SE - Svezia 149
FI - Finlandia 117
FR - Francia 111
RU - Federazione Russa 87
CA - Canada 68
IN - India 67
ID - Indonesia 64
KR - Corea 52
TR - Turchia 49
AR - Argentina 37
UA - Ucraina 37
JP - Giappone 36
NL - Olanda 30
BE - Belgio 28
MX - Messico 26
BG - Bulgaria 25
LT - Lituania 24
PL - Polonia 24
CO - Colombia 21
ES - Italia 20
MY - Malesia 20
TW - Taiwan 19
IQ - Iraq 18
CZ - Repubblica Ceca 14
VE - Venezuela 14
CL - Cile 13
EC - Ecuador 13
IR - Iran 13
AT - Austria 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
AU - Australia 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
MA - Marocco 9
PK - Pakistan 9
AL - Albania 8
UZ - Uzbekistan 8
EG - Egitto 6
KE - Kenya 6
NP - Nepal 6
TH - Thailandia 6
CR - Costa Rica 5
IL - Israele 5
JM - Giamaica 5
MT - Malta 5
RO - Romania 5
RS - Serbia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
OM - Oman 4
PH - Filippine 4
BH - Bahrain 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
GA - Gabon 2
HN - Honduras 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
Totale 9.237
Salva come PNG Salva come JPEG
Città #
Ashburn 546
Singapore 442
Santa Clara 409
Dublin 314
Chandler 310
San Jose 264
Hong Kong 222
Fairfield 219
Dallas 157
Southend 150
Hefei 142
Council Bluffs 121
Beijing 118
Nyköping 112
Woodbridge 112
Helsinki 104
Ann Arbor 99
New York 97
Seattle 96
London 92
Wilmington 89
Ho Chi Minh City 82
Houston 82
Modena 79
Los Angeles 73
Cambridge 72
The Dalles 64
Hanoi 62
Dearborn 59
Milan 52
Seoul 51
Jakarta 45
Lauterbourg 45
Rome 42
Bologna 41
Munich 40
Jacksonville 38
Moscow 37
Fremont 34
Shanghai 34
Chicago 31
São Paulo 30
San Diego 28
Redwood City 27
Sofia 24
Princeton 23
Brussels 22
Orem 21
Buffalo 20
Columbus 20
Tokyo 20
Frankfurt am Main 19
San Giuliano Milanese 19
Toronto 19
Paris 18
Parma 18
Reggio Emilia 18
Bremen 17
Dong Ket 17
Warsaw 17
Brooklyn 15
Eugene 15
Redondo Beach 15
Falls Church 14
Mumbai 14
Phoenix 14
Portsmouth 14
Florence 13
Denver 12
Montreal 12
Düsseldorf 11
Guangzhou 11
Haiphong 11
New Taipei 11
Izmir 10
Nuremberg 10
Boardman 9
Chennai 9
Genoa 9
Poplar 9
Salt Lake City 9
Baghdad 8
Bari 8
Brno 8
Caprarola 8
Cardiff 8
Charlotte 8
Da Nang 8
Glasgow 8
Kent 8
Mexico City 8
Naples 8
Stockholm 8
Tashkent 8
Istanbul 7
Johannesburg 7
Medellín 7
Melbourne 7
Norwalk 7
Ottawa 7
Totale 6.068
Salva come PNG Salva come JPEG
Nome #
GD2 expression in breast cancer. 427
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 398
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 392
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 380
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 363
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 362
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 355
The evolving role of microsatellite instability in colorectal cancer: A review 351
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 345
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 344
A concise review of lenalidomide therapy for follicular lymphoma 341
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 317
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 313
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 305
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 304
Breast Location for De Novo Extramedullary Myeloid Sarcoma 290
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 290
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 274
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 271
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 261
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 259
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 257
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 254
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 235
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 229
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 226
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 215
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 202
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 194
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 191
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 165
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 162
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 36
Totale 9.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022625 43 79 34 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/20251.718 58 35 61 119 325 239 131 108 188 106 140 208
2025/20263.705 238 98 317 331 447 219 528 198 359 363 280 327
2026/2027102 102 0 0 0 0 0 0 0 0 0 0 0
Totale 9.308